BMJ  2006;332:1163-1164 (20 May), doi:10.1136/bmj.332.7551.1163

Editorial

Ethnicity and adverse drug reactions

Personalised drug treatment is getting closer but will not replace good clinical judgment

The first 150 words of the full text of this article appear below.

Whether ethnicity is an important contributor to the variable outcome of drug treatment is still a matter of debate. Research evidence on such associations is limited in quantity and variable in quality. Too often patients' ethnicity is classified by using poorly defined criteria or an inadequate scientific basis.1 Indeed, both skin colour and self identification of ethnic origin seem to be poorly correlated with molecular genetics, and most genetic variability is found within, rather than among, continental populations.2 In addition, ethnic differences in drug response might originate from cultural or environmental factors.

In a meta-analysis on p 1177 McDowell and colleagues systematically reviewed the literature and summarised consistent findings about ethnicity and adverse drug reactions to cardiovascular drugs.3 They found, among other interesting results, a threefold higher risk of angioedema in black compared to non-black patients when taking angiotensin converting enzyme inhibitors as well as a doubled risk of . . . [Full text of this article]

Optimising dose


Genetic markers


Clinical judgment and deeper knowledge


Erik Eliasson, associate professor

Karolinska Institutet, Division of Clinical Pharmacology, Karolinska University Hospital Huddinge, SE 141 86 Stockholm, Sweden
(erik.eliasson@ki.se)


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Articles

Pharmacovigilance in developing countries
Munir Pirmohamed, Kwame N Atuah, Alex N O Dodoo, and Peter Winstanley
BMJ 2007 335: 462. [Extract] [Full Text] [PDF]

Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine
Sarah E McDowell, Jamie J Coleman, and R E Ferner
BMJ 2006 332: 1177-1181. [Abstract] [Full Text] [PDF]

This article has been cited by other articles:

  • Pirmohamed, M., Atuah, K. N, Dodoo, A. N O, Winstanley, P. (2007). Pharmacovigilance in developing countries. BMJ 335: 462-462 [Full text]  
  • (2006). Ethnicity Affects Reactions to Cardiovascular Drugs. JWatch General 2006: 5-5 [Full text]  



Access all current jobs at BMJ Group
Whats new online at Student 

BMJ
Listen to the latest 

BMJ Interview